Clinical trial
Elderly Influenza Vaccine Immunogenicity Substudy
NCT00170482 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00170482 |
|---|---|
| Title | Elderly Influenza Vaccine Immunogenicity Substudy |
| Official title | In Depth Immunologic Studies in Elderly Subjects Receiving Either Standard-Dose Fluzone (15mcg HA/Virus Strain) or High-Dose (60 mcg HA/Virus Strain) Trivalent Inactivated Influenza Virus Vaccine |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Influenza |
| Enrollment | 60 |
| Start date | Apr 25, 2005 |
| Primary completion | May 30, 2005 |
| Completion | May 30, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 28, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: